Rituxan (rituximab) - Roche
A stepwise institutional approach to refractory autoimmune cytopenia after allogeneic stem cell transplantation in children: a retrospective case series. (PubMed, Front Immunol) - Oct 3, 2026 - "All received corticosteroids (± IVIG) and rituximab...Because treatment was not randomised, this apparent advantage may reflect patient selection rather than true efficacy. These observations are exploratory and require prospective validation." 
Journal • Retrospective data • Bone Marrow Transplantation • Graft versus Host Disease • Hematological Disorders • Immunology • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42824157
 
Bei Yan; Fan Jiang; Jiao Chen; Linlin Lv; Shifen Fan; Yuan Sun; Zhouyang Liu
 
Oct 3, 2026
 
Prev Next